Rural Health
Resources by Topic: Substance use and misuse
Fetal Death in Tennessee, 2017-2021: 2024 Report
Describes the characteristics and trends of reportable fetal deaths in Tennessee from 2017-2021. Features statistics including fetal mortality rate with breakdowns by 6 levels of population density.
Date: 06/2024
Sponsoring organization: Tennessee Department of Health
view details
Describes the characteristics and trends of reportable fetal deaths in Tennessee from 2017-2021. Features statistics including fetal mortality rate with breakdowns by 6 levels of population density.
Date: 06/2024
Sponsoring organization: Tennessee Department of Health
view details
Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use Drugs
Presents a study on the barriers to healthcare and social services access for older adults in rural communities who use drugs. Bases findings on survey results from rural adults over 50 who use drugs on perceived barriers to service utilization. Highlights how barriers such as a lack of transportation, health insurance, and permanent housing correlates with age.
Author(s): Beth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Citation: Journal of Applied Gerontology, 43(12), 1977-1984
Date: 06/2024
view details
Presents a study on the barriers to healthcare and social services access for older adults in rural communities who use drugs. Bases findings on survey results from rural adults over 50 who use drugs on perceived barriers to service utilization. Highlights how barriers such as a lack of transportation, health insurance, and permanent housing correlates with age.
Author(s): Beth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Citation: Journal of Applied Gerontology, 43(12), 1977-1984
Date: 06/2024
view details
FY24-FY26 New Mexico State Health Improvement Plan (SHIP) Summary
Outlines New Mexico's disease prevention and health promotion plan for fiscal years 2024-2026. Identifies health priorities and strategies to increase access to primary care, reduce the incidence of substance misuse and mental health conditions, improve environmental health, and increase prevention and support for those affected by adverse childhood experiences. Includes discussion of tribal and rural health needs.
Date: 06/2024
Sponsoring organization: New Mexico Department of Health
view details
Outlines New Mexico's disease prevention and health promotion plan for fiscal years 2024-2026. Identifies health priorities and strategies to increase access to primary care, reduce the incidence of substance misuse and mental health conditions, improve environmental health, and increase prevention and support for those affected by adverse childhood experiences. Includes discussion of tribal and rural health needs.
Date: 06/2024
Sponsoring organization: New Mexico Department of Health
view details
Stress, Mental Health, and Risk-Taking: Associations among a Sample of Agricultural Adolescents
Reports on a survey of 298 adolescents living on farms about mental health, anxiety, and risk-taking behaviors related to weapons, violence, and substance use. Discusses the implications of study findings with regard to access to mental healthcare.
Author(s): Josie M. Rudolphi, Richard L. Berg
Citation: International Journal of Research and Public Health, 21(7), 830
Date: 06/2024
view details
Reports on a survey of 298 adolescents living on farms about mental health, anxiety, and risk-taking behaviors related to weapons, violence, and substance use. Discusses the implications of study findings with regard to access to mental healthcare.
Author(s): Josie M. Rudolphi, Richard L. Berg
Citation: International Journal of Research and Public Health, 21(7), 830
Date: 06/2024
view details
New Mexico Substance Use Epidemiology Profile, 2024
Provides county-level data on substance use in New Mexico for youth and adults, with breakdowns by race/ethnicity. Covers alcohol, illicit drugs, tobacco, and mental health. Addresses deaths due to drug overdoses, smoking, alcohol, suicide, alcohol-related chronic disease, and motor vehicle crashes. Includes emergency room visits related to opioid overdoses, and chronic liver disease hospital discharges.
Date: 06/2024
Sponsoring organization: New Mexico Department of Health
view details
Provides county-level data on substance use in New Mexico for youth and adults, with breakdowns by race/ethnicity. Covers alcohol, illicit drugs, tobacco, and mental health. Addresses deaths due to drug overdoses, smoking, alcohol, suicide, alcohol-related chronic disease, and motor vehicle crashes. Includes emergency room visits related to opioid overdoses, and chronic liver disease hospital discharges.
Date: 06/2024
Sponsoring organization: New Mexico Department of Health
view details
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more. Requires the creation of a free account to view.
Author(s): Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date: 06/2024
Sponsoring organization: The Milken Institute
view details
Evaluates factors associated with geographic remoteness of 60 miles or more from the nearest phase 2 or 3 clinical trial for a variety of health conditions. Discusses American Indian reservations and rural areas, and provides data on demographic factors associated with remoteness including race and ethnicity, educational attainment, and poverty. Includes a county-level interactive map of clinical trial remoteness for health conditions including cancers, substance use disorder, diabetes, obesity, COPD, stroke, and more. Requires the creation of a free account to view.
Author(s): Andrew Friedson, Bumyang Kim, Maggie Switek, Lawson Mansell
Date: 06/2024
Sponsoring organization: The Milken Institute
view details
Assessing How Alcohol Use Patterns Relate to Obesity among American Adolescents from Rural and Urban Areas: Five Years of Pooled Data
Analyzes the association between alcohol use and obesity among rural and urban adolescents aged 12-17. Utilizes 2015-2019 National Survey on Drug Use and Health data.
Author(s): Christian E. Vazquez, Fawn A. Brown, Faheem Ohri, Philip Baiden
Citation: PLoS ONE, 19(6), e0305638
Date: 06/2024
view details
Analyzes the association between alcohol use and obesity among rural and urban adolescents aged 12-17. Utilizes 2015-2019 National Survey on Drug Use and Health data.
Author(s): Christian E. Vazquez, Fawn A. Brown, Faheem Ohri, Philip Baiden
Citation: PLoS ONE, 19(6), e0305638
Date: 06/2024
view details
Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
view details
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
view details
Evaluation of the Vermont All-Payer Accountable Care Organization Model: 2018-2022 - Fourth Evaluation Report
Evaluates the first five performance years of the Vermont All-Payer Accountable Care Organization Model (VTAPM), which aims to assess whether scaling an Accountable Care Organization (ACO) across all payers in the state can reduce program expenditures while preserving or improving care quality. Discusses the implementation of the model, provider engagement, efforts to address population health goals; characteristics of participating hospitals, practitioners, and beneficiaries; and the model's impacts on Medicare spending, utilization, and quality of care. Includes analyses of Medicare ACO subgroups and Medicaid spending, utilization, and quality of care trends. Outlines challenges and lessons learned.
Additional links: Findings at a Glance, Technical Appendices
Date: 06/2024
Sponsoring organizations: Centers for Medicare and Medicaid Services, NORC at the University of Chicago
view details
Evaluates the first five performance years of the Vermont All-Payer Accountable Care Organization Model (VTAPM), which aims to assess whether scaling an Accountable Care Organization (ACO) across all payers in the state can reduce program expenditures while preserving or improving care quality. Discusses the implementation of the model, provider engagement, efforts to address population health goals; characteristics of participating hospitals, practitioners, and beneficiaries; and the model's impacts on Medicare spending, utilization, and quality of care. Includes analyses of Medicare ACO subgroups and Medicaid spending, utilization, and quality of care trends. Outlines challenges and lessons learned.
Additional links: Findings at a Glance, Technical Appendices
Date: 06/2024
Sponsoring organizations: Centers for Medicare and Medicaid Services, NORC at the University of Chicago
view details
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Sponsoring organization: Centers for Disease Control and Prevention
view details
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Sponsoring organization: Centers for Disease Control and Prevention
view details